Mountain Valley MD Holdings Inc (CSE:MVMD) (OTCMKTS:MVMDF) CEO Dennis Hancock talks to Proactive about the Vancouver, British Columbia-based biotechnology's upcoming milestones on the horizon. Hancock says the group heads into 2021 with no debt and enough funding to help form business development partnerships with pharmaceutical companies.
He adds the group is having 'very advanced' discussions with pharma in potentially licensing out its products.
Price: 1.44 CAD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Mountain Valley MD Holdings Inc named herein, including the promotion by the Company of Mountain Valley MD Holdings Inc in any Content on the...
FOR OUR FULL DISCLAIMER CLICK HERE
Mountain Valley MD (CSE: MVMD- OTCQB: MVMDF) Director of Life Scienced Mike Farber joined Steve Darling from Proactive with news the company has announced they are adding the South African Variant to their upcoming Bio Safety Level 4 lab study, which is analyzing viral clearance efficacy with...
Health
Industry & services
Basic Materials
